AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 296: H1274-H1280, 2009. First published February 27, 2009; doi:10.1152/ajpheart.00008.2009
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/5/H1274    most recent
00008.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Favaloro, J. L.
Right arrow Articles by Kemp-Harper, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Favaloro, J. L.
Right arrow Articles by Kemp-Harper, B. K.

Redox variants of NO (NO· and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms

Joanne L. Favaloro1 and Barbara K. Kemp-Harper2

1School of Medical Sciences, Royal Melbourne Institute of Technology University, Bundoora West; and 2Department of Pharmacology, Monash University, Clayton, Victoria, Australia

Submitted 7 January 2009 ; accepted in final form 24 February 2009

The free radical form of nitric oxide (NO·) is a well-known mediator of vascular tone. What is not so well recognized is that NO· exists in several different redox forms. There is considerable evidence that NO· and its one-electron reduction product, nitroxyl (HNO), have pharmacologically distinct actions that extend into the regulation of the vasculature. The aim of this study was to compare the vasorelaxation mechanisms of HNO and NO·, including an examination of the ability of these redox variants to hyperpolarize and repolarize vascular smooth muscle cells from rat mesenteric arteries. The HNO donor Angeli's salt (0.1 nM–10 µM) caused a concentration-dependent hyperpolarization of vessels at resting tone and a simultaneous, concentration-dependent vasorelaxation and repolarization of vessels precontracted and depolarized with methoxamine. Both vasorelaxation and repolarization responses to Angeli's salt were significantly attenuated by both the HNO scavenger L-cysteine (3 mM) and the voltage-dependent K+ (Kv) channel inhibitor 4-aminopyridine (4-AP; 1 mM) and virtually abolished by the soluble guanylate cyclase (sGC) inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 10 µM) or 30 mM K+. In contrast, NO· (0.01–1 µM) repolarized arteries to a lesser extent than HNO, and these responses were resistant to inhibition by ODQ (10 µM) and 4-AP (1 mM). Blockade of Kv channels (1 mM 4-AP) also significantly inhibited the repolarization response to YC-1 (0.1–10 µM), confirming a role for sGC/cGMP in the activation of Kv channels in this preparation. We conclude that HNO causes vasorelaxation via a cGMP-dependent activation of Kv channels and that there are different profiles of vasorelaxant activity for the redox siblings HNO and NO·.

nitroxyl; hyperpolarization; soluble guanylate cyclase; K+ channels; nitric oxide



Address for reprint requests and other correspondence: J. Favaloro, Discipline of Pharmaceutical Sciences, School of Medical Sciences, Royal Melbourne Institute of Technology, Univ., PO Box 71, Bundoora West, Victoria 3083, Australia (e-mail: Joanne.Favaloro{at}rmit.edu.au)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.